Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 17 Thoracic 8 Lymphoid 8 Genitourinary 7 Breast 6 Dermatologic 4 CNS 4 Plasma cell 3 Other solid neoplasm 3 Other hematologic neoplasm 3 Head & Neck 3 Tumor-Agnostic 2 Sarcoma 2 Gynecologic 2 Other neoplasm 1 Myeloid 1

Conditions

Rare Malignant Neoplasm 1

Interventions

Cyclophosphamide 13 Biopsy 13 fludarabine phosphate 9 Whole-Body Irradiation 9 Surveys and Questionnaires 9 Peripheral Blood Stem Cell Transplantation 9 Busulfan 9 Polymerase Chain Reaction 7 Mycophenolic Acid 7 Early Intervention, Educational 7 Tacrolimus 6 Gene Expression Profiling 6 Educational Status 6 Colposcopy 6 Carboplatin 6 fludarabine 5 Paclitaxel 5 Microarray Analysis 5 Methotrexate 5 Methods 5 Melphalan 5 Immunohistochemistry 5 Epoetin Alfa 5 Decitabine 5 Cyclosporine 5 Cisplatin 5 Celecoxib 5 Antilymphocyte Serum 5 Aminolevulinic Acid 5 Sulindac 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pharmaceutical Preparations × Other neoplasm × Clear all

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡